Menu
GeneBe

NFAT5

nuclear factor of activated T cells 5, the group of Nuclear factors of activated T-cells |IPT domain containing

Basic information

Region (hg38): 16:69565093-69704666

Links

ENSG00000102908NCBI:10725OMIM:604708HGNC:7774Uniprot:O94916AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NFAT5 gene.

  • Immunodeficiency (534 variants)
  • Inborn genetic diseases (41 variants)
  • not provided (15 variants)
  • not specified (6 variants)
  • NFAT5-related condition (6 variants)
  • Immunodeficiency and Autoimmune Enterocolopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NFAT5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
152
clinvar
12
clinvar
168
missense
305
clinvar
3
clinvar
4
clinvar
312
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
1
inframe indel
13
clinvar
3
clinvar
16
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
9
10
2
21
non coding
22
clinvar
19
clinvar
41
Total 0 0 326 180 35

Variants in NFAT5

This is a list of pathogenic ClinVar variants found in the NFAT5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-69566340-A-C NFAT5-related disorder Likely benign (Aug 16, 2022)3049105
16-69568504-A-G not specified Uncertain significance (May 27, 2022)2211886
16-69626426-A-G Uncertain significance (-)1174700
16-69626496-C-T Uncertain significance (Jul 15, 2022)2501730
16-69647057-A-G Immunodeficiency Uncertain significance (Apr 20, 2019)838968
16-69647058-T-C not specified Uncertain significance (Aug 14, 2023)2618164
16-69647062-C-T Immunodeficiency Likely benign (Mar 26, 2023)2904384
16-69647063-G-A Immunodeficiency Uncertain significance (Apr 17, 2022)2421991
16-69647068-T-C Immunodeficiency Likely benign (Jul 12, 2022)1083683
16-69647099-A-G Immunodeficiency • not specified Uncertain significance (Oct 29, 2023)1948500
16-69647100-C-T Immunodeficiency Uncertain significance (Jul 05, 2022)1469216
16-69647101-C-T Immunodeficiency Likely benign (Oct 23, 2022)2196081
16-69647109-C-G not specified Uncertain significance (Jun 22, 2023)2605556
16-69647113-C-T Immunodeficiency Likely benign (Dec 23, 2020)1647942
16-69647115-C-T Immunodeficiency Uncertain significance (Nov 21, 2023)2698015
16-69647120-A-G Immunodeficiency Uncertain significance (Oct 05, 2020)1044496
16-69647122-C-A Immunodeficiency Likely benign (Jan 18, 2023)2829974
16-69647123-G-A Immunodeficiency Uncertain significance (May 01, 2023)2070978
16-69647125-C-T Immunodeficiency Likely benign (Jul 03, 2023)2972835
16-69647135-A-T Immunodeficiency Uncertain significance (Oct 21, 2020)1026296
16-69647146-G-C Immunodeficiency Uncertain significance (Aug 20, 2021)1041218
16-69647161-C-T Immunodeficiency Likely benign (Nov 24, 2023)2719091
16-69647162-G-A Immunodeficiency Benign (Sep 23, 2022)526781
16-69647164-G-T Immunodeficiency Likely benign (Jul 03, 2022)1954939
16-69647176-C-G not specified Uncertain significance (Mar 16, 2022)2278674

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NFAT5protein_codingprotein_codingENST00000432919 14139573
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.000001921257180301257480.000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.135377840.6850.000037910215
Missense in Polyphen171324.280.527324316
Synonymous1.132632870.9150.00001492991
Loss of Function7.15976.40.1180.00000417804

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002940.0000294
Ashkenazi Jewish0.000.00
East Asian0.0008940.000870
Finnish0.00009590.0000924
European (Non-Finnish)0.00008490.0000791
Middle Eastern0.0008940.000870
South Asian0.00003680.0000327
Other0.0001900.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcription factor involved, among others, in the transcriptional regulation of osmoprotective and inflammatory genes. Mediates the transcriptional response to hypertonicity (PubMed:10051678). Positively regulates the transcription of LCN2 and S100A4 genes; optimal transactivation of these genes requires the presence of DDX5/DDX17 (PubMed:22266867). Binds the DNA consensus sequence 5'- [ACT][AG]TGGAAA[CAT]A[TA][ATC][CA][ATG][GT][GAC][CG][CT]-3' (PubMed:10377394). {ECO:0000269|PubMed:10051678, ECO:0000269|PubMed:10377394, ECO:0000269|PubMed:22266867}.;

Recessive Scores

pRec
0.302

Intolerance Scores

loftool
0.439
rvis_EVS
-1.37
rvis_percentile_EVS
4.45

Haploinsufficiency Scores

pHI
0.855
hipred
Y
hipred_score
0.532
ghis
0.638

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.514

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nfat5
Phenotype
growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype;

Zebrafish Information Network

Gene name
nfat5a
Affected structure
pericardium
Phenotype tag
abnormal
Phenotype quality
edematous

Gene ontology

Biological process
cytokine production;transcription by RNA polymerase II;signal transduction;excretion;calcineurin-NFAT signaling cascade;positive regulation of transcription by RNA polymerase II;regulation of calcineurin-NFAT signaling cascade;cellular response to cytokine stimulus;positive regulation of NIK/NF-kappaB signaling;positive regulation of leukocyte adhesion to vascular endothelial cell
Cellular component
nucleus;nucleoplasm;transcription factor complex;cytosol;nuclear transcription factor complex
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;DNA-binding transcription factor activity;protein binding;transcription factor binding